A Study of Famitinib in Patients With Advanced Colorectal Cancer

NCT01762293 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Colorectal Cancer Metastatic
Colorectal Cancer Recurrent

Interventions

DRUG: Famitinib
OTHER: placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Collaborators

[object Object]
[object Object]